Bristol lung cancer setback puts rival Merck drug in driver seat savita thakur thakur12 Oct 2016 1:12 PM ISTNew data is likely to prompt doctors to abandon Bristol-Myers Squibb's immunotherapy Opdivo in favor of Merck & Co's rival Keytruda in a large...
Exelixis and Pfizer drugs compete in kidney cancer trial savita thakur thakur12 Oct 2016 1:11 PM ISTCopenhagen : Exelixis's drug Cabometyx outperformed Pfizer's Sutent in a clinical study for the treatment of metastatic kidney cancer, suggesting it...
Geistlich dental products to be available in India savita thakur thakur11 Oct 2016 10:04 AM ISTNew Delhi : Swiss medical products firm Geistlich Pharma AG said two of its globally patented products used for dental regeneration will now be...
Mylan to pay $465 mn over EpiPen overcharges to Medicaid savita thakur thakur11 Oct 2016 10:02 AM ISTNew York : Mylan will pay $465 million to resolve accusations from some regulators that it over billed the federal Medicaid program for the EpiPen...
AstraZeneca CEO: Bristol drug flop opens big cancer opportunity savita thakur thakur11 Oct 2016 10:02 AM ISTCopenhagen : The failure of Bristol-Myers Squibb's blockbuster Opdivo immunotherapy in previously untreated lung cancer patients has opened up the...
India’s struggle to introduce dengue vaccines savita thakur thakur10 Oct 2016 11:55 AM ISTNew Delhi : Dengue is a dangerous debilitating disease that occasionally kills people and has no known cure or treatment.Two vaccines against the...
Ajanta Pharmas Guwahati facility to be ready by Mar 2017 savita thakur thakur10 Oct 2016 11:53 AM ISTMumbai : Drug maker Ajanta Pharma said its new formulations facility at Guwahati will be commercialised before March 2017 and Dahej manufacturing...
Pfizer to seek more modern headquarters in Manhattan savita thakur thakur10 Oct 2016 11:52 AM ISTPfizer Inc, the largest U.S. drugmaker, said it aims to sell its world headquarters buildings in midtown Manhattan by the end of 2017 and begin moving...
Merck's Keytruda achieves 24 percent response in bladder cancer study savita thakur thakur10 Oct 2016 9:53 AM ISTMerck & Co's immunotherapy Keytruda proved effective as an initial treatment for nearly a quarter of patients with advanced bladder cancer too...
AstraZeneca licenses respiratory drug to Insmed savita thakur thakur9 Oct 2016 10:33 AM ISTDrugmaker Insmed Inc said it had bought the rights to an experimental early-stage respiratory drug from Britain's AstraZeneca Plc in a deal worth $150...
Dr Reddy's forays into Colombian market; to sell cancer drugs savita thakur thakur9 Oct 2016 10:33 AM ISTNew Delhi : Dr Reddy's Laboratories announced its entry into the Colombian market with its portfolio of cancer drugs."Our company has a track record...
Lupin, MonoSol Rx sign pact for multiple pediatric products savita thakur thakur9 Oct 2016 9:33 AM ISTNew Delhi : Drug firm Lupin and US-based specialty pharmaceutical firm MonoSol Rx have signed a licensing agreement for multiple pediatric...
